MSVEX Mutual Fund

MSVEX Mutual Fund

NAV$6.48
Do a full portfolio x-ray with MSVEX
Just $25 once·$69/mo·Download sample
Get mine for $25

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.30%
Dividend Yield (Current)
1.21%
Holdings
33
Inception Date
Dec 31, 2021
Fund Family
Morgan Stanley Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+1.07%
1 Year+29.13%
3 Year+2.90%

Asset Allocation

Stocks: 98.41%
Cash: 1.59%
Do a full portfolio x-ray with MSVEX
$25 once. No subscription. Download sample.
Get mine for $25

Top Holdings

View All →
TickerNameWeight
ARGX:ASArgenx Se Sponsored Adr (1 Ads : 1 Ordinary)8.03%
LLYEli Lilly & Co.7.79%
ASND:COAscendis Pharma As Adr5.48%
NKTRNektar Therapeutics Class A4.75%
TMOThermo Fisherscientific Inc.4.28%
Top 10 Concentration: 49.11%Report Date: Mar 31, 2026
Download all 33 holdings for MSVEX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.21%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MSVEX Mutual Fund Overview

MSVEX Mutual Fund (Vitality Portfolio Class A) is managed by Morgan Stanley Investment Management. MSVEX expense ratio is 1.30%, holding 33 positions across sectors including Health Care, Information Technology. Inception date: 2021-12-31.

MSVEX performance shows a YTD return of 1.07%. The 1-year return is 29.13%. MSVEX dividend yield stands at 1.21%, paid annually.

MSVEX top holdings include Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (8.0%), Eli Lilly & Co. (7.8%), Ascendis Pharma As Adr (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisherscientific Inc. (4.3%). Go to all MSVEX holdings, MSVEX sectors, or MSVEX dividends.

MSVEX can be compared against other funds. Use MSVEX overlap to find shared positions, or MSVEX vs another fund for a side-by-side view. MSVEX alternatives are available via the screener, along with tax-loss harvesting opportunities.